Open AccessPrivate sector vaccine share in overall immunization coverage in India: Evidence from private sector vaccine utilization data (2012-2015)
Author(s) -
Habib Hasan Farooqui,
Sanjay Zodpey
Publication year - 2020
Publication title -
indian journal of public health/indian journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.381
H-Index - 26
eISSN - 2229-7693
pISSN - 0019-557X
DOI - 10.4103/ijph.ijph_433_18
Subject(s) - immunization , medicine , private sector , hepatitis b vaccine , vaccination , rotavirus vaccine , diphtheria , environmental health , pneumococcal conjugate vaccine , public sector , measles , virology , immunology , economic growth , rotavirus , hbsag , hepatitis b virus , political science , streptococcus pneumoniae , economics , virus , genetics , antigen , biology , bacteria , law
The objective of this research was to generate the evidence on the private sector's contribution to overall immunization coverage for selected pediatric vaccines in India. Using IMS Health's (now IQVIA) vaccine sales audit data and innovative methodological approach we estimated private-sector vaccine share in the total immunization coverage across selected pediatric vaccines in India. Our estimates suggest that private sector remains an important contributor to immunization services in India not only for Universal Immunization Program vaccines (Bacillus Calmette-Guérin [19.23%], HiB pentavalent [11.09%], hepatitis B [5.75%], oral poliovirus vaccine [5.48%], Diphtheria-Pertussis-Tetanus [2.66%], and measles [2.17%]) but also for newer vaccines (hepatitis A [4.2%], rotavirus [3.4%], typhoid [3.3%], and pneumococcal conjugate vaccine [2.5%]). As the private sector continues to remain an important access point for immunization services in the country, avenues for potential synergy between public and private sectors should be explored to improve the coverage and quality of immunization services.